- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Glioblastoma Pipeline Sees Surge in Treatments
Over 200 companies working on 220+ therapies, according to DelveInsight report.
Mar. 31, 2026 at 2:50pm
Got story updates? Submit your updates here. ›
Cutting-edge imaging techniques reveal the complex inner workings of glioblastoma, a deadly brain cancer that is the focus of an expanding treatment pipeline.According to a new report from DelveInsight, the global glioblastoma pipeline is seeing a surge in activity, with over 200 key companies continuously working on developing more than 220 different treatment therapies for this aggressive form of brain cancer.
Why it matters
Glioblastoma is one of the most deadly and difficult-to-treat forms of brain cancer, with a median survival rate of just 12-15 months. The expansion of the treatment pipeline offers hope for new and potentially more effective therapies to combat this devastating disease.
The details
The DelveInsight report provides a comprehensive analysis of the current glioblastoma pipeline, including details on the key companies involved, the mechanisms of action and routes of administration for the various therapies in development, as well as updates on ongoing clinical trials.
- The report was published on March 31, 2026.
The players
DelveInsight
A leading healthcare consulting and market intelligence firm that provides comprehensive industry reports and analysis.
What’s next
The report's findings suggest that the glioblastoma treatment landscape is rapidly evolving, with numerous promising therapies in the pipeline. Patients, clinicians, and researchers will be closely monitoring the progress of these new treatments as they advance through clinical trials.
The takeaway
The surge in glioblastoma treatment development represents a significant step forward in the fight against this devastating form of brain cancer, offering new hope for patients and their families.
